• Prenatal diagnosis of Down syndrome in pregnant woman with giant uterine myoma and hereditary thrombophilia

Prenatal diagnosis of Down syndrome in pregnant woman with giant uterine myoma and hereditary thrombophilia

HEALTH OF WOMAN. 2018.3(129):24–30; doi 10.15574/HW.2018.129.24

Veropotvelyan N. P. , Gazarova L. V. , Pogulyay Yu. S. , Savarovskaya E. S. , Sporish V. G. , Enotova N. V. , Finiti A. S.
SI «Interregional Center for Medical Genetics and Prenatal Diagnostics named after P.N. Verophotlyana «DOS», Krivoi Rog
SI
«Dnipropetrovsk Regional Clinical Hospital named after II Mechnikov», Dnepr
SI
«Dnepropetrovsk regional pathoanatomical bureau», Dnepr

The article describes the case of prenatal diagnosis of Down’s syndrome in a 17 weeks of gestation fetus in a 39-year-old pregnant woman with the first detected giant necrotic uterine myoma and a tendency to hypercoagulable against the background of the heterozygous carriage of the Leyden mutation. At 20 weeks of gestation, due to the inability to proliferate through the natural birth canal, extirpation of the uterus with the fetus (without appendages) was carried out along the Rhine-Poros. At autopsy the diagnosis was confirmed. Timely medical and prophylactic measures allowed to avoid the development of thrombogenic complications. The article discusses the complications of the course of pregnancy with uterine myomas, as well as the features of the echographic pattern of degenerative changes in the myomatous nodes, indications for an operative delivery for uterine myomas, and the frequency of carriage of the Leiden mutation in the population.
Key words: uterine myoma, Leyden mutation, ultrasound diagnosis,invasive prenatal diagnosis, Down’s syndrome.

REFERENCES

1. Sidorova IS. 2003. Mioma matki (sovremennyie aspektyi etiologii, patogeneza, klassifikatsii i profilaktiki). M, MIA:5–66.

2. Shilyaev AYu. 2005. Leyomioma matki (v pomosch nachinayuschemu vrachu). Ginekologiya 7;1:65–70.

3. Vihlyaeva EM. 2004. Rukovodstvo po diagnostike i lecheniyu leyomiomyi matki. M, MEDpress-inform:312.

4. Savitskiy GA, Savitskiy AG. 2000. Mioma matki. SPB, «ELBI–SPb»:90–139.

5. Kohanevich EV, Sidorov EV. 2006. Aktualnyie voprosyi akusherstva, ginekologii i reproduktologii. M, «Triada-H»:303–315.

6. Tihomirov AL, Lubnin DM. 2006. Mioma matki. M, MIA:176.

7. Sidorova IS. 1985. Mioma matki i beremennost. M, Meditsina:192.

8. Mihalevich SI, Kapusta AV. 2011. Beremennost, rodyi i poslerodovoy period u zhenschin s miomoy matki. Meditsinskie novosti 2:18–25.

9. Tihomirova II, Mayorova OV, Valetova VV, Zubkov VV, Saharova AA. 2006. Gigantskaya mioma matki, oslozhnennaya ileofemoralnyim trombozom i tromboemboliey legochnoy arterii. Akusherstvo i ginekologiya 3:53–55.

10. Tsytohenetychni metody doslidzhennia khromosom liudyny. Metodychni rekomendatsii. K. 2003.

11. Shmakov GS, Uvarova EV, Yakovleva AN. 1978. Yavlyaetsya li mioma matki faktorom riska rozhdeniya nasledstvenno otyagoschennyih detey. V kn.: Voprosyi reabilitatsii pri miome matki. M:95–101.

12. Veropotvelyan NP. 2017. Effektivnost prenatalnoy diagnostiki sindroma Dauna v shesti oblastyah Tsentralnogo i Yugo-Vostochnogo regionov Ukrainyi. Zdorove zhenschiny 4:20–30.

13. Bulanov NM. 2010. Ultrazvukovaya ginekologiya: kurs lektsiy v treh tomah. T. 1. M, «Vidar-M»:205–203.

14. Kalashnikova EA, Kokarovtseva SN, Kovalenko TF, Sirotkina OV, Sheydina AM, Zorilova IV, Illarioshkin SN, Patrushev LI. 2006. Chastotyi mutatsiy v genah faktora V (FV Leiden), protrombina (G20210A) i 5,10-metilentetragidrofolatreduktazyi (C677T) u russkih. Meditsinskaya genetika 7:27–29.

15. Aytkulova AM, Tarlyikov PV, Zholdyibaeva EV. 2013. Rol nekotoryih geneticheskih markerov v razvitii restenozov v razlichnyih populyatsiyah. Eurasian journal of applied biotechnology 4:4–12.

16. Veropotvelian MP, Pohuliai YuS, Klymenko SV, Arbuzova SB. 2015. Reproduktyvni rozlady, asotsiiovani z henetychno zumovlenoiu skhylnistiu do hiperkoahuliatsii. Zdorove zhenshchynы 7:130–133.

17. Makukh HV. 2012. Mutatsii, shcho uspadkovuiutsia yak henetychnyi tiahar: chastota, fenotypovi asotsiatsii, diahnostyka. Avtoref. dys. d-ra bіol. nauk. K.

18. Guis F, Ville Y, Vincent Y, Doumerc S, Pons JC, Frydman R. 1995. Ultrasound evaluation of the length of the nasal bone throughout gestation. Ultrasound Obstet Gynecol. 5:304–307. https://doi.org/10.1046/j.1469-0705.1995.05050304.x; PMid:7614133

19. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. 2001. Absence of nasal bone in fetuseswith trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet. 358:1665–1667. https://doi.org/10.1016/S0140-6736(01)06709-5

20. Sonek J, Nicolaides KN. 2002. Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol. 186:139–41. https://doi.org/10.1067/mob.2002.119082; PMid:11810099

21. Medvedev MV, Altyinnik NA. 2003. Dlina kostey nosa ploda v 12-14 ned beremennosti kak prenatalnyiy ehograficheskiy marker hromosomnyih anomaliy. Prenat. diagn. 2;1:66–70.

22. Bethune M. 2007. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone. Australas Radiol. 51:218. https://doi.org/10.1111/j.1440-1673.2007.01713.x; PMid:17504311

23. Kozlova OI. 2007. Dlina kostey nosa ploda kak prenatalnyiy ehograficheskiy marker hromosomnyih anomaliy. Dis. kand.med.nauk. M.

24. Veropotvelyan NP, Bondarenko AA. 2017. Ultrazvukovoy skrining i katamnez euploidnyih plodov s aplaziey/gipoplaziey nosovyih kostey. Prenatalnaya diagnostika 16;1:22–31.

25. Dash P, Puri RD, Goyal M, Bijarnia S, Lall M, Kotecha U, Verma IC. 2015. Absent/Hypoplastic Fetal Nasal Bone and Its Association with Aneuploidies. Journal of Fetal Medicine 2:75–78. https://doi.org/10.1007/s40556-015-0051-1

26. Benacerraf BR, Barss VA, Laboda LA. 1985. A sonographic sign for the detection in the second trimester of the fetus with Down’s syndrome. Am J Obstet Gynecol. 151:1078–1079. https://doi.org/10.1016/0002-9378(85)90385-0

27. Snijders RJM, Nicolaides KN. 1996. Ultrasound markers for fetal chromosomal defects. N.Y., L.: The Pantheon Publishing Group.: 191.

28. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD. 1992. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med. 11:449. https://doi.org/10.7863/jum.1992.11.9.449; PMid:1283415

29. Biagiotti R, Periti E, Cariati E. 1994. Humerus and femur length in fetuses with Down syndrome. Prenat Diagn. 14:429–434. https://doi.org/10.1002/pd.1970140603; PMid:7937578

30. FitzSimmons J, Droste S, Shepard TH, Pascoe-Manson J, Chinn A, Mack LA. 1989. Long bone growth in fetuses with Down syndrome. Am J Obstet Gynecol. 161:1174–1177. https://doi.org/10.1016/0002-9378(89)90658-3